Compass Therapeutics Inc
CMPX
Get informed when a big investor buys or sells
+ FollowMarket Cap$283.49M
Close$
$0.13
93.5% downside
Current Fair Value
93.5% downsideOvervalued by 93.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $283.49 Million |
|---|---|
| Enterprise Value | $238.11 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.42 |
| Beta | 0.75 |
| Outstanding Shares | 186,400,000 |
Return
| Return on Equity | -36.56% |
|---|---|
| Return on Assets | -33.23% |
| Return on Invested Capital | -28.54% |
Valuation & Multiples
| P/E Ratio | -4.82 |
|---|---|
| PEG | -47.64 |
| Price to Sales | - |
| Price to Book Ratio | 2.04 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -4.28 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
$-0.10
Average shareholder expectationRevenue Estimate
$-818,182
Average shareholder expectationNext Earnings Call
Expected Date
August 10, 2026
EPS Estimate
$-0.10
Average shareholder expectationRevenue Estimate
$-600,000
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0570▲ 5.70% |
|---|---|
| Total Calls | 3,312,300▲ Infinity% |
| Total Puts | 188,900▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 109.86%▼ 8.85% |
|---|---|
| Total Invested | $919.10M▲ 4.27% |
| Investors Holding | 209▲ 36.00% |
ESG Score
No data